Pizarra, Mercedes D.
HRN: 25-35-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/18/2026
01/18/2026
IV
4.5g
Now
Complicated UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines